Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q4 2014

Baupost Group

Portfolio at the end of Q4 2014, from the 13F filed February 13, 2015. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
Cheniere Energy LNG · history 19.1% $972.0M 13,807,230 $70.40 Q1 2014 Add 23%
Viasat VSAT · history 14.3% $726.9M 11,533,137 $63.03 Q2 2013 or earlier No change
Micron Technology MU · history 13.6% $689.9M 19,706,035 $35.01 Q2 2013 or earlier Reduce 62%
eBay EBAY · history 10.3% $522.8M 9,315,000 $56.12 Q2 2014 Add 53%
Antero Resources AR · history 6.3% $318.5M 7,847,831 $40.58 Q3 2014 Add 184%
Innoviva INVA · history 5.5% $280.4M 19,815,983 $14.15 Q2 2013 or earlier No change
Keryx Biopharmaceuticals KERX · history 5.1% $258.9M 18,300,000 $14.15 Q1 2014 No change
PBF Energy PBF · history 4.5% $230.8M 8,663,114 $26.64 Q3 2013 Add 21%
Veritiv VRTV · history 2.4% $120.0M 2,314,193 $51.87 Q3 2014 Reduce 2%
Forward Pharma FWP · history 2.2% $111.8M 5,367,300 $20.83 Q4 2014 Buy
Theravance Biopharma TBPH · history 1.8% $90.4M 6,061,228 $14.92 Q2 2014 No change
Onity Group OCN · history 1.8% $90.1M 5,967,050 $15.10 Q3 2014 Reduce 15%
Citigroup C.WS · warrants · history 1.8% $89.3M 102,673,007 $0.87 Q2 2013 or earlier Reduce 16%
SunEdison Semiconductor SEMI · history 1.5% $77.0M 4,145,379 $18.57 Q2 2014 No change
ChipMOS IMOS · history 1.5% $76.6M 3,283,235 $23.32 Q2 2013 or earlier No change
Bellatrix Exploration BXE · history 1.3% $65.9M 18,103,713 $3.64 Q4 2014 Buy
Novagold Resources NG · history 1.3% $64.0M 21,688,300 $2.95 Q2 2013 or earlier No change
Paratek Pharmaceuticals PRTK · history 1.2% $62.1M 1,735,218 $35.79 Q4 2014 Buy
Kosmos Energy KOS · history 1.2% $60.8M 7,242,354 $8.39 Q2 2014 Add 52%
Atara Biotherapeutics ATRA · history 1.2% $59.1M 2,495,913 $23.69 Q4 2014 Buy
Innoviva INVA.CV · convertible notes · history 0.6% $31.4M 40,089,000 prn Q3 2014 Add 135%
Syneron Medical ELOS · history 0.4% $22.5M 2,416,310 $9.33 Q2 2013 or earlier Reduce 19%
Kindred Biosciences KIN · history 0.4% $22.5M 3,013,848 $7.45 Q4 2013 No change
American International Group AIG.WS · warrants · history 0.4% $21.9M 889,387 $24.62 Q2 2013 or earlier Add 13%
Alon USA Partners ALDW · history 0.2% $12.3M 954,188 $12.91 Q4 2013 Add 190%
Pyxus International AOI · history 0.2% $10.1M 6,383,641 $1.58 Q2 2013 or earlier No change
Trilogy Metals TMQ · history 0.1% $2.9M 6,005,298 $0.49 Q2 2013 or earlier No change
27 positions100.0%$5.09B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2014, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Energy32.6%
Health care18.4%
Technology16.6%
Media & telecom14.3%
Consumer discretionary10.3%
Financials & real estate4.0%
Industrials2.4%
Materials1.3%
Consumer staples0.2%

What changed from Q3 2014

← Q3 2014 Q1 2015 →